Literature DB >> 16797094

Guidelines for primary radiotherapy of patients with prostate cancer.

Dirk Boehmer1, Philippe Maingon, Philip Poortmans, Marie-Hélène Baron, Raymond Miralbell, Vincent Remouchamps, Christopher Scrase, Alberto Bossi, Michel Bolla.   

Abstract

BACKGROUND AND PURPOSES: The appropriate application of 3-D conformal radiotherapy, intensity modulated radiotherapy or image guided radiotherapy for patients undergoing radiotherapy for prostate cancer requires a standardisation of target delineation as well as clinical quality assurance procedures. PATIENTS AND METHODS: Pathological and imaging studies provide valuable information on tumour extension. In addition, clinical investigations on patient positioning and immobilisation as well as treatment verification data offer an abundance of information.
RESULTS: Target volume definitions for different risk groups of prostate cancer patients based on pathological and imaging studies are provided. Available imaging modalities, patient positioning and treatment preparation studies as well as verification procedures are collected from literature studies. These studies are summarised and recommendations are given where appropriate.
CONCLUSIONS: On behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Radiation Oncology Group this article presents a common set of recommendations for external beam radiotherapy of patients with prostate cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16797094     DOI: 10.1016/j.radonc.2006.05.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  48 in total

1.  Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer.

Authors:  Marlies Pasler; Dietmar Georg; Holger Wirtz; Johannes Lutterbach
Journal:  Strahlenther Onkol       Date:  2011-11-29       Impact factor: 3.621

2.  Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.

Authors:  Kareem N Rayn; Jonathan B Bloom; Samuel A Gold; Graham R Hale; Joseph A Baiocco; Sherif Mehralivand; Marcin Czarniecki; Vikram K Sabarwal; Vladimir Valera; Bradford J Wood; Maria J Merino; Peter Choyke; Baris Turkbey; Peter A Pinto
Journal:  J Urol       Date:  2018-05-29       Impact factor: 7.450

3.  Management of low-risk prostate cancer.

Authors:  Robert A Gardiner; Freddie C Hamdy
Journal:  World J Urol       Date:  2008-09-19       Impact factor: 4.226

4.  Preoperative Prediction of Extracapsular Extension: Radiomics Signature Based on Magnetic Resonance Imaging to Stage Prostate Cancer.

Authors:  Shuai Ma; Huihui Xie; Huihui Wang; Jiejin Yang; Chao Han; Xiaoying Wang; Xiaodong Zhang
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

5.  Role of 3.0 T multiparametric MRI in local staging in prostate cancer and clinical implications for radiation oncology.

Authors:  F Couñago; M Recio; E Del Cerro; L Cerezo; A Díaz Gavela; F J Marcos; R Murillo; J M Rodriguez Luna; I J Thuissard; J L R Martin
Journal:  Clin Transl Oncol       Date:  2014-05-28       Impact factor: 3.405

6.  Real-time adaptive planning method for radiotherapy treatment delivery for prostate cancer patients, based on a library of plans accounting for possible anatomy configuration changes.

Authors:  Maria Antico; Peter Prinsen; Francesco Cellini; Alice Fracassi; Alfonso A Isola; David Cobben; Davide Fontanarosa
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

7.  Physical and clinical implications of radiotherapy treatment of prostate cancer using a full bladder protocol.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Dario Zerini; Federica Cattani; Flavia Serafini; Rosa Luraschi; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

Review 8.  Hypofractionated radiotherapy for localized prostate cancer.

Authors:  Stefan Höcht; Daniel M Aebersold; Clemens Albrecht; Dirk Böhmer; Michael Flentje; Ute Ganswindt; Tobias Hölscher; Thomas Martin; Felix Sedlmayer; Frederik Wenz; Daniel Zips; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2016-09-14       Impact factor: 3.621

9.  Dose impact of rectal gas on prostatic IMRT and VMAT.

Authors:  Motoharu Sasaki; Hitoshi Ikushima; Masahide Tominaga; Takeshi Kamomae; Taro Kishi; Masataka Oita; Masafumi Harada
Journal:  Jpn J Radiol       Date:  2015-11-17       Impact factor: 2.374

Review 10.  Radiation therapy approaches to the treatment of high-risk prostate cancer.

Authors:  Soroush Rais-Bahrami; Manish A Vira; Louis Potters
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.